Regional Business Manager - Oklahoma City
Intellia Therapeutics, Inc.
July 01, 2026
On-site
Cambridge, MA
Sales
Responsibilities
- Develop and execute comprehensive territory plans targeting immunologists, allergists, emergency medicine physicians, and specialized HAE treatment centers
- Identify and prioritize high-value accounts based on HAE patient volume, prescriber influence, and institutional capabilities
- Establish trusted advisor relationships with key opinion leaders, clinical champions, and administrative decision-makers
- Maintain a robust sales pipeline from initial awareness through patient treatment completion
- Educate healthcare providers on in vivo CRISPR gene editing mechanisms and differentiate from ex vivo cell therapies and traditional treatments
- Clearly articulate MOA differentiation vs prophylactic treatments, complement inhibitors, and plasma-derived therapies; present Phase III efficacy and safety data
- Address misconceptions about CRISPR safety and differentiate vs previous gene therapy launches; educate on unmet needs
- Maintain competitive intelligence; develop differentiated value propositions; proactively handle objections (CRISPR tech, permanent genetic modification, single-treatment cost)
- Educate the patient pathway from diagnosis confirmation through treatment administration
- Coordinate with patient support hubs to ensure seamless patient experience and treatment access
- Partner with Medical Science Liaisons; align with Field Reimbursement Managers on payer strategy and coverage; work with strategic accounts on referral patterns and site activation
Qualifications/Skills
- Comprehensive knowledge of hereditary angioedema pathophysiology, treatment landscape, and unmet needs
- Understanding of gene editing technologies, genetic medicines, and regulatory requirements
- Ability to analyze and present complex clinical trial data and real-world evidence
- Exceptional scientific communication; proven relationship-building with stakeholders
- Creative problem solving, collaboration, growth mindset, competitive mindset, and business-owner execution/results
- BS/BA in life sciences or business-related field
- Preferred: rare disease/gene therapy/HAE market knowledge
- Required/Preferred Experience: 5+ years specialty pharmaceutical sales (rare diseases/immunology/genetic medicines preferred); launch experience; proven rare disease commercialization; success in 12–18 month complex sales with multiple stakeholders
Benefits/Compensation
- Performance-based annual cash bonus; new hire equity grant; potential annual equity awards
Application instructions
- Applications accepted on a rolling basis until position is filled.
- Develop and execute comprehensive territory plans targeting immunologists, allergists, emergency medicine physicians, and specialized HAE treatment centers
- Identify and prioritize high-value accounts based on HAE patient volume, prescriber influence, and institutional capabilities
- Establish trusted advisor relationships with key opinion leaders, clinical champions, and administrative decision-makers
- Maintain a robust sales pipeline from initial awareness through patient treatment completion
- Educate healthcare providers on in vivo CRISPR gene editing mechanisms and differentiate from ex vivo cell therapies and traditional treatments
- Clearly articulate MOA differentiation vs prophylactic treatments, complement inhibitors, and plasma-derived therapies; present Phase III efficacy and safety data
- Address misconceptions about CRISPR safety and differentiate vs previous gene therapy launches; educate on unmet needs
- Maintain competitive intelligence; develop differentiated value propositions; proactively handle objections (CRISPR tech, permanent genetic modification, single-treatment cost)
- Educate the patient pathway from diagnosis confirmation through treatment administration
- Coordinate with patient support hubs to ensure seamless patient experience and treatment access
- Partner with Medical Science Liaisons; align with Field Reimbursement Managers on payer strategy and coverage; work with strategic accounts on referral patterns and site activation
Qualifications/Skills
- Comprehensive knowledge of hereditary angioedema pathophysiology, treatment landscape, and unmet needs
- Understanding of gene editing technologies, genetic medicines, and regulatory requirements
- Ability to analyze and present complex clinical trial data and real-world evidence
- Exceptional scientific communication; proven relationship-building with stakeholders
- Creative problem solving, collaboration, growth mindset, competitive mindset, and business-owner execution/results
- BS/BA in life sciences or business-related field
- Preferred: rare disease/gene therapy/HAE market knowledge
- Required/Preferred Experience: 5+ years specialty pharmaceutical sales (rare diseases/immunology/genetic medicines preferred); launch experience; proven rare disease commercialization; success in 12–18 month complex sales with multiple stakeholders
Benefits/Compensation
- Performance-based annual cash bonus; new hire equity grant; potential annual equity awards
Application instructions
- Applications accepted on a rolling basis until position is filled.